Tensor decomposition based unsupervised feature extraction applied to drug discovery from gene expression analysis
Presentation at the 5th IITM-Tokyo Tech symposium.
"Current trends in Bioinformatics: Big data analysis, machine learning and drug design", will be held on 6th - 7th March 2020 in IITM
https://web.iitm.ac.in/bioinfo2/symposium2020/home
from gene expression profiles of drug treated cancer cell lines Project 2: Integrated analysis of gene expression profiles of drug treated tissues and human patients Project 3: Inference of drug efective to Alzheimer disease of mice brain single cell gene expression (without drug treated gene expression)
with data of “dose density(i) ⨉ compounds(j) ⨉ gene(l)” → Tensors can be decomposed. x ijl G u k1i u k2j u k3l x ijl ≒ΣΣ k1,k2,k3 G k1,k2,k3 u k1i u k2j u k3l gene compounds dose density compounds dose density gene
of genes and compounds with dose dependence by tensor decomposition Target proteins identification by the comparisons with single gene KO/KI experiments Validation by the comparison with known drug target proteins by Fisher’s exact test, Over all data analysis flow
in integrated analysis of gene expression between diseases and DrugMatrix datasets Y.-h. Taguchi Scientific Reports volume 7, Article number: 13733 (2017) OPEN ACCESS
ijl Tensor decomposition G u k1i u k2j u k3l x ijl =x ij ×x il ≒ΣΣ k1,k2,k3 G k1,k2,k3 u k1i u k2j u k3l i:genes j:Patients vs healthy contol l:dose density Patients vs healthy contol Dose density
3 i =x j 1 j 2 i x j 3 i =∑G(l 1 ,l 2 ,l 3 ,l 4 )u l 1 j 1 u l 2 j 2 u l 3 j 3 u l 4 i x j 1 j 2 i u l 1 j 1 u l 2 j 2 u l 3 j 3 u l 4 i j 1 j 2 j 3 i Compounds Time dulation after treatment Patients vs Health control gene Gene X Target protein
with primary biliary cirrhosis”, Drug Des Devel Ther. 2015 ;9:5407-19. CONCLUSION: Combination therapy improved liver biochemistry and the prognosis of PBC, but did not improve clinical symptoms or incidence of death. Attention should be paid to adverse events when using bezafibrate.
tissues (Cortex and Hippocampus), Four ages (3, 6, 12, and 21 weeks), Two sexes (male and female) Four 96 well plates (the number of cells). Aim: Understanding Alzheimer’s disease
j 5 j 6 =∑ l 1 l 2 l 3 l 4 l 5 l 6 l 7 G(l 1 ,l 2 ,l 3 ,l 4 ,l 5 ,l 6 ,l 7 ) ×u l 1 j 1 u l 2 j 2 u l 3 j 3 u l 4 j 4 u l 5 j 5 u l 6 j 6 u l 7 i (A) u l1j1 :96 wells (cells), l 1 =1 (B) u l2j2 : genotype APP_NL-F-G vs C57Bl/6, l 2 =1 (C) u l3j3 : Cortex vs Hippocampus, l 3 =1 (D) u l4j4 : 3, 6, 12, 21 weeks , l 4 =2 (E) u l5j5 : female vs male, l 5 =1 (F) u l6j6 : 4 plates , l 1 =1 → l 7 =2 with G(1,1,1,2,1,1,l 7 ) (the largest absolute values)
] Attributing P-values to genes After correcting P-values by BH criterion, 401 genes with P i <0.01 are selected. → Evaluate how these are overlapped with genes affected by known Alzheimer’s drug treatments. 401 genes are uploaded to Enrichr
gene expression profile using TD based unsupervised FE I have published a monograph from Springer. I am happy if you can but it, although it is extremely expensive.